熱門資訊> 正文
展望Therapeutics股价在定价500万美元后下跌
2026-03-24 19:11
- Outlook Therapeutics (OTLK) shares fell 34% in premarket trading Tuesday after the company priced a public offering.
- The biopharma firm is selling 20M shares along with warrants to buy up to 20M shares at a combined price of $0.25. The offering is expected to raise about $5M before fees.
- The warrants are exercisable immediately at $0.25 per share and will expire in five years. The offering is expected to close around March 25, 2026, subject to standard conditions.
- Outlook Therapeutics intends to use the net proceeds from the offering primarily for working capital and general corporate purposes.
- Source: Press Release
More on Outlook Therapeutics
- Third Time's The Charm: Outlook Therapeutics' Lytenava Heads To FDA, Again
- Biggest stock movers Tuesday: CLB, OTLK, and more
- Outlook Therapeutics drops 80% on CRL for BLA for wet AMD asset
- Seeking Alpha’s Quant Rating on Outlook Therapeutics
- Historical earnings data for Outlook Therapeutics
推薦文章
美股機會日報 | 特朗普再放豪言！正與伊朗談判，並收到伊方「大禮」；特斯拉機器人再迎新進展！馬斯克稱有望明年實現量產
一圖看懂 | 單季盈利承壓！拼多多Q4營收1239億元同比增12%，調后淨利卻下跌12%；高管稱「力爭三年再造一個拼多多」
財報前瞻 | 美團Q4財報將放榜！大摩、高盛逆勢力挺股價，當前美團已嚴重超跌？
中東戰火中金價狂瀉11%！創43年最慘周跌，避險邏輯崩塌還是黃金坑？
美股機會日報 | 中東硝煙將散？以官員稱美方4月9日結束對伊戰爭！海力士擬籌資百億赴美上市，豪擲80億美元鎖定阿斯麥光刻機！
一圖看懂 | 連續5個季度破千億！小米Q4營收1169億創歷史新高；淨利大增43.8%至63億元
無論美伊談判真假！華爾街已從特朗普引發的五分鍾狂飆獲得明確信號？
麥格理：緊張局勢緩和后布倫特原油底部在每桶85至90美元
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
